Evolution of CD8⁺ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer

Engineered T cell receptor T (TCR-T) cell therapy has facilitated the generation of increasingly reliable tumor antigen-specific adaptable cellular products for the treatment of human cancer. TCR-T cell therapies were initially focused on targeting shared tumor-associated peptide targets, including...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yimo Sun, Fenge Li, Heather Sonnemann, Kyle R. Jackson, Amjad H. Talukder, Arjun S. Katailiha, Gregory Lizee
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2021-09-01
Serie:	Cells
Soggetti:	T-cell receptor (TCR) engineered TCR-T cell therapy tumor antigen clinical trials cancer treatment
Accesso online:	https://www.mdpi.com/2073-4409/10/9/2379
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!